© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > “compound 27”
<< Back to October
potent pan-PIM kinase inhibitor
oral PD and efficacy in xenograft model
from SBDD of prior lead
Bioorg. Med. Chem. Lett., Oct. 14, 2020
Sanofi, Waltham/Cambridge, MA
“compound 27” (Sanofi oral in vivo pan-PIM kinase inhibitor)
Unlock this content with a Premium membership to read it now.